BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19033390)

  • 1. p53 is localized to a sub-nucleolar compartment after proteasomal inhibition in an energy-dependent manner.
    Karni-Schmidt O; Zupnick A; Castillo M; Ahmed A; Matos T; Bouvet P; Cordon-Cardo C; Prives C
    J Cell Sci; 2008 Dec; 121(Pt 24):4098-105. PubMed ID: 19033390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Energy-dependent nucleolar localization of p53 in vitro requires two discrete regions within the p53 carboxyl terminus.
    Karni-Schmidt O; Friedler A; Zupnick A; McKinney K; Mattia M; Beckerman R; Bouvet P; Sheetz M; Fersht A; Prives C
    Oncogene; 2007 May; 26(26):3878-91. PubMed ID: 17237827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome inhibitors induce nucleolar aggregation of proteasome target proteins and polyadenylated RNA by altering ubiquitin availability.
    Latonen L; Moore HM; Bai B; Jäämaa S; Laiho M
    Oncogene; 2011 Feb; 30(7):790-805. PubMed ID: 20956947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo.
    Xirodimas D; Saville MK; Edling C; Lane DP; Laín S
    Oncogene; 2001 Aug; 20(36):4972-83. PubMed ID: 11526482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nucleolus directly regulates p53 export and degradation.
    Boyd MT; Vlatkovic N; Rubbi CP
    J Cell Biol; 2011 Sep; 194(5):689-703. PubMed ID: 21893597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of soluble and nucleolar-associated p53 proteins following cellular stress.
    Klibanov SA; O'Hagan HM; Ljungman M
    J Cell Sci; 2001 May; 114(Pt 10):1867-73. PubMed ID: 11329373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the MDM2-p53 pathway by the nucleolar protein CSIG in response to nucleolar stress.
    Xie N; Ma L; Zhu F; Zhao W; Tian F; Yuan F; Fu J; Huang D; Lv C; Tong T
    Sci Rep; 2016 Nov; 6():36171. PubMed ID: 27811966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.
    Moumen A; Masterson P; O'Connor MJ; Jackson SP
    Cell; 2005 Dec; 123(6):1065-78. PubMed ID: 16360036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway.
    Chang YC; Lee YS; Tejima T; Tanaka K; Omura S; Heintz NH; Mitsui Y; Magae J
    Cell Growth Differ; 1998 Jan; 9(1):79-84. PubMed ID: 9438391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled access of p53 to the nucleus regulates its proteasomal degradation by MDM2.
    Davis JR; Mossalam M; Lim CS
    Mol Pharm; 2013 Apr; 10(4):1340-9. PubMed ID: 23398638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of histone deacetylase 2 induces p53-dependent survivin downregulation through MDM2 proteasomal degradation.
    Seo SK; Hwang CS; Choe TB; Hong SI; Yi JY; Hwang SG; Lee HG; Oh ST; Lee YH; Park IC
    Oncotarget; 2015 Sep; 6(28):26528-40. PubMed ID: 25605253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation.
    Hjerpe R; Aillet F; Lopitz-Otsoa F; Lang V; Torres-Ramos M; Farrás R; Hay RT; Rodríguez MS
    Int J Biochem Cell Biol; 2010 May; 42(5):725-35. PubMed ID: 20080206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasome inhibitor induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5.
    Pokrovskaja K; Mattsson K; Kashuba E; Klein G; Szekely L
    J Gen Virol; 2001 Feb; 82(Pt 2):345-358. PubMed ID: 11161273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumor suppressor SHIP1 colocalizes in nucleolar cavities with p53 and components of PML nuclear bodies.
    Ehm P; Nalaskowski MM; Wundenberg T; Jücker M
    Nucleus; 2015; 6(2):154-64. PubMed ID: 25723258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of p53 and p21Waf1 expression on G2/M phase arrest of colorectal carcinoma HCT116 cells to proteasome inhibitors.
    Kim OH; Lim JH; Woo KJ; Kim YH; Jin IN; Han ST; Park JW; Kwon TK
    Int J Oncol; 2004 Apr; 24(4):935-41. PubMed ID: 15010833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleolar stress induces ubiquitination-independent proteasomal degradation of PICT1 protein.
    Maehama T; Kawahara K; Nishio M; Suzuki A; Hanada K
    J Biol Chem; 2014 Jul; 289(30):20802-12. PubMed ID: 24923447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholic acid modulates the ubiquitin-proteasome degradation pathway of p53.
    Amaral JD; Castro RE; Solá S; Steer CJ; Rodrigues CM
    Biochem Biophys Res Commun; 2010 Oct; 400(4):649-54. PubMed ID: 20807506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death.
    Lee JH; Kim HS; Lee SJ; Kim KT
    J Cell Sci; 2007 Jul; 120(Pt 13):2259-71. PubMed ID: 17591690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation.
    Stommel JM; Wahl GM
    EMBO J; 2004 Apr; 23(7):1547-56. PubMed ID: 15029243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nuclear import of p53 in relation to MDM2-mediated degradation and ubiquitination].
    Li HP; Zhang YP
    Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):86-9. PubMed ID: 15946545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.